Glycogen Synthase Kinase-3

• Glycogen Synthase Kinase-3, Peter Crouch, Adam Cole, Michael Cousin, Ana Martinez, and Katja Kanninen
  Volume 2011 (2011), Article ID 279234, 1 page
• Deconstructing GSK-3: The Fine Regulation of Its Activity, Miguel Medina and Francisco Wandosell
  Volume 2011 (2011), Article ID 479249, 12 pages
• What Are the bona fide GSK3 Substrates?, Calum Sutherland
  Volume 2011 (2011), Article ID 505607, 23 pages
• The Role of GSK3 in Presynaptic Function, Karen Janet Smillie and Michael Alan Cousin
  Volume 2011 (2011), Article ID 263673, 8 pages
• GSK3 Function in the Brain during Development, Neuronal Plasticity, and Neurodegeneration, Pamela Salcedo-Tello, Abril Ortiz-Matamoros, and Clorinda Arias
  Volume 2011 (2011), Article ID 189728, 12 pages
• GSK-3 in Neurodegenerative Diseases, Peng Lei, Scott Ayton, Ashley I. Bush, and Paul A. Adlard
  Volume 2011 (2011), Article ID 189246, 9 pages
• Regulation of Cell Survival Mechanisms in Alzheimer's Disease by Glycogen Synthase Kinase-3, Marjelo A. Mines, Eleonore Beurel, and Richard S. Jope
  Volume 2011 (2011), Article ID 861072, 11 pages
• Glycogen Synthase Kinase-3β: A Mediator of Inflammation in Alzheimer's Disease?, Jari Koistinaho, Tarja Malm, and Gundars Goldsteins
  Volume 2011 (2011), Article ID 129753, 9 pages
• Functional Implications of Glycogen Synthase Kinase-3-Mediated Tau Phosphorylation, Diane P. Hanger and Wendy Noble
  Volume 2011 (2011), Article ID 352805, 11 pages
• Targeting Glycogen Synthase Kinase-3β for Therapeutic Benefit against Oxidative Stress in Alzheimer's Disease: Involvement of the Nrf2-ARE Pathway, Katja Kanninen, Anthony R. White, Jari Koistinaho, and Tarja Malm
  Volume 2011 (2011), Article ID 985085, 9 pages
• Glycogen Synthase Kinase 3 Inhibitors in the Next Horizon for Alzheimer's Disease Treatment, Ana Martinez, Carmen Gil, and Daniel I. Perez
  Volume 2011 (2011), Article ID 280502, 7 pages